Enlarged Prostate Treatment Options
Struggling with BPH symptoms (benign prostatic hyperplasia)?
Knowing about common BPH treatments can help when talking with your doctor about your concerns.
How BPH Treatment Options Stack Up
The treatment plan you and doctor decide on will likely be influenced by many factors, including quality of life, importance of certain activities, potential side effects, and level of risk involved. See how typical BPH treatment options align with common treatment goals.
Which goals are most important to you?
| Treatment Goal |
Medications1–5 | UroLift® System Procedure6–11 |
Water Vapor Therapy12–15 |
Laser/TURP1,16–18 |
|---|---|---|---|---|
| Minimally invasive treatment that addresses prostate blockage | N/A |
Reduces blockage. Can be performed in a doctor's office with local anesthesia |
Reduces blockage. Can be performed in a doctor's office with local anesthesia |
Reduces blockage. Typically done in a hospital or surgery center with increased anesthesia |
| Quick recoverya | N/A |
88–100% reported little or no interference at ~1 month |
50–60% reported little or no interference at ~1 month |
DATA NOT AVAILABLE |
| Minimal catheter use after procedureb | N/A |
10–32% catheter ratec |
75–100% catheter rate |
~100% catheter rate |
| Low risk of serious complications |
Floppy iris syndrome |
3–7% urinary infection |
7–17% urinary infection |
10–20% urinary infection |
| Sexual preservation |
3–5% erectile dysfunction, |
0% erectile dysfunction, |
0% erectile dysfunction, |
7–10% erectile dysfunction, |
| One-time treatment without ongoing side effects |
Daily requirement to take medications with associated side effects such as headaches, dizziness, lack of energy, insomnia and nasal congestion while on treatment |
Typically, a one-time procedure with associated side effects such as temporary blood in urine and pain |
Typically, a one-time procedure with associated side effects such as temporary blood in urine and pain |
Typically, a one-time procedure with associated side effects such as temporary blood in urine and pain |
| Significant symptom relief |
4–7pt IPSS at 12 mo |
10–11pt IPSS at 12 mo |
10–11pt IPSS at 12 mo |
~15pt IPSS at 12 mo |
| Long-lasting relief |
Daily pill needed |
2–3% per year retreatment |
1–2% per year retreatment |
1–2% per year retreatment |
Reduces blockage. Can be performed in a doctor's office with local anesthesia
Reduces blockage. Can be performed in a doctor's office with local anesthesia
Reduces blockage. Typically done in a hospital or surgery center with increased anesthesia
88–100% reported little or no interference at ~1 month
50–60% reported little or no interference at ~1 month
AVAILABLE
10–32% catheter ratec
75–100% catheter rate
~100% catheter rate
Floppy iris syndrome
Depression & self-harm
3–7% urinary infection <1% urethral scarring, 0–2% bleedingd, <1% bladder stonese
7–17% urinary infection, 0–4% urethral scarring, 0–1% bleedingd
10–20% urinary infection, 3–7% urethral scarring, 2–6% bleedingd, 0–2% urine leakagef, 0–1% TUR syndrome
3–5% erectile dysfunction, 1–10% ejaculatory dysfunction
0% erectile dysfunction, 0% ejaculatory dysfunctiong
0% erectile dysfunction, 3–20% ejaculatory dysfunction
7–10% erectile dysfunction, 40–60% ejaculatory dysfunction
Daily requirement to take medications with associated side effects such as headaches, dizziness, lack of energy, insomnia and nasal congestion while on treatment
Typically, a one-time procedure with associated side effects such as temporary blood in urine and pain
Typically, a one-time procedure with associated side effects such as temporary blood in urine and pain
Typically, a one-time procedure with associated side effects such as temporary blood in urine and pain
4–7pt IPSS at 12 mo
10–11pt IPSS at 12 mo
10–11pt IPSS at 12 mo
~15pt IPSS at 12 mo
Daily pill needed
2–3% per year retreatment
1–2% per year retreatment
1–2% per year retreatment
a. Recovery is defined as return to normal daily activities with little or no interference (Tutrone, Can J Urol 2020). TURP/Laser not studied with this definition of recovery.
b. Based on patients who underwent a voiding trial.
c. Excludes patients with obstructive median lobes for the UroLift™ System, who are estimated to account for ~5% of the eligible UroLift System population.
d. Includes severe bleeding only (clinically defined as Clavien-Dindo grade IIIb)
e. Patients treated with the post-FDA clearance technique requiring a procedure to specifically remove an implant. This was studied in a clinical trial with >1,400 patients.
f. Urinary leakage due to sudden pressure on the bladder from activities such as exercise, laughing, coughing, sneezing etc. (clinically known as stress urinary incontinence)
g. UroLift System definition of erectile and ejaculatory dysfunction requires new onset and sustained event. Other therapies described have different definitions of sexual preservation.
References
1. AUA BPH Guidelines 2003. Updated 2020.
2. McConnell, N Engl J med 2003;349:2387-98
3. Chang DF, Campbell JR, J Cataract Refract Surg. 2005 Apr; 31(4): 664-673
4. Duan et al, Pharmacoepidemiol Drug Saf. 2018 Mar; 27(3): 340-348
5. Welk et al, JAMA Intern Med. 2017 May 1; 177(5): 683-691
6. Roehrborn, J Urol 2013; 190(6): 2161-7
7. Roehrborn, Can J Urol 2017; 24(3): 8802-8813
8. Shore Can J Urol 2014
9. Tutrone, Can J Urol 2020
10. Eure, et al., AUA 2020
11. Sonksen, et al., Eur Urol 2015 Oct; 68(4): 643-52
12. McVary, J Urol 2016; 195(5):1529-1538
13. McVary, J Urol 2020; 203(4S): AUA abstract LBA01-06 5-year Rezum
14. Mollengarden, et al., Prostate Cancer Prostatic Dis 2018 Sep; 21(3): 379-385
15. Yang, WCE 2018
16. Bachmann, et al., Eur Urol 2014; 65(5): 931-942
17. Strope, Urology 2015; 86: 1115-1122
18. Rassweiler, et al., Eur Urol 2006; 50(5): 969-980
MAC02259-05A,p5
What are my options?
If you have BPH symptoms that are just not improving, or are getting worse over time, it's important to talk with your urologist.
Medications
These include alpha blockers, which relax bladder neck muscles, and 5-alpha reductase inhibitors which act to shrink the prostate.
UroLift™ System
Small implants are placed to lift or hold excess tissue out of the way so it no longer blocks the urethra – with no heating, cutting, or removal, of prostate tissue.3,4
Thermotherapies
Heat, such as steam or hot water, is applied directly to the prostate to destroy excess tissue.
Laser
Concentrated light is used to generate precise, intense heat to destroy excess prostate tissue.
Waterjet Ablation
A high-velocity waterjet is used to destroy excess prostate tissue, using an image-guided robotic arm.
Transurethral Resection (TURP)
An electric wire loop or laser fiber is used to remove or vaporize excess prostate tissue.
Learn About Common BPH Medications
The UroLift System - What to Expect
Don't Hesitate to Ask Your Doctor
Many people aren’t comfortable talking about sensitive health topics, even with their doctor, and may downplay or avoid discussing their worsening urinary issues. Health care professionals, especially urologists, often talk with people about urinary problems, and the good news is, BPH symptoms are generally treatable. Discussing your health concerns is the first step towards finding solutions.
Don't hesitate to ask your doctor about minimally invasive procedures like the UroLift™ System.
You May Need to Ask
Let your doctor know if BPH medications aren't helping enough or if you have concerns about potential side effects. Ask about minimally invasive treatment options that align with your treatment goals.
75%
Surveyed said they weren't informed about minimally invasive procedures as an alternative to BPH medications*
Take Care of #1
Part of the standard of care,6 the UroLift™ System can be used to treat a broad spectrum of anatomies, including lateral and obstructive median lobe and prostates up to 100cc.4,5
#1
The UroLift™ System is the #1 chosen minimally invasive BPH procedure in the U.S.**
Don't Let BPH Hurt Your Sex Life
Patients treated with the UroLift™ System achieved better reported outcomes in sexual function§ and satisfaction than men who received BPH medication.3
57%
Of men surveyed believe that BPH affects their relationships and 61% say it impacts sex*
For procedures
- How fast will I experience BPH symptom relief?
- What level of symptom relief can I expect?
- What are the common side effects?
- What are the anesthesia options; is a hospital stay required?
- Would I go home with a catheter?
- When can I return to normal activity?
For medications
-
What level of symptom relief can I expect?
-
What side effects are typical and are any serious?
-
Will I always need to be on BPH medications and are they known to be effective over time?
-
Will delaying having a procedure increase my risk of bladder or kidney disease?
-
If medications aren't helping enough, what are my options?
"The advice I would give to men who experience BPH is not to sit around and think it's going to go away...go get yourself checked out." ‡
- Corey B, Age 52
Frequently Asked Questions
How long do UroLift results typically last?
Our pivotal study with the Urolift System treatment has reported durable outcomes out to 5 years.1 A real-world study found that 88.4% of UroLift patients did not require a secondary surgical procedure through 5-years2.
See PublicationsFrequently Asked Questions
Is the UroLift procedure permanent, and can the implants be removed if needed?
The UroLift System implant is designed to be a permanent implant. The UroLift implants are made from standard surgical materials and have been tested for biocompatibility.
A real-world study showed that 88.4% of patients receiving the UroLift System treatment did not need a second surgical treatment through 5-years.2
The UroLift System treatment does not prevent future UroLift System, TURP, or laser procedures if recommended by your physician.1
Frequently Asked Questions
How does the UroLift System treatment compare to other treatment options?
The UroLift™ System is the only leading BPH MIST* with consistent durability in a controlled trial and real-world setting.1,2,3 The UroLift™ System is a comprehensively studied minimally invasive BPH procedure, with over 145 peer-reviewed and 22 sponsored publications.
The UroLift procedure is a minimally invasive procedure which can be performed as a same day outpatient procedure, including the office setting, under local anesthesia.4 The UroLift™ system treatment is a minimally invasive procedure, it has rapid symptom relief and recovery.4,5
References:
*Rezūm™, UroLift™ System
1. Roehrborn, Can J Urol 2017 2. Kaplan, Prostate Cancer Prostatic Dis 2023 3. U.S. 2023 estimates based on US Market Model 2023-25 (3-14-23 FINAL), which is in part based on Symphony Health PatientSource® 2018-22, as is and with no representations/warranties, including accuracy or completeness. 4. Shore, Can J Urol 2014 5. Roehrborn, J Urology 2013
MAC03242-08 Rev A
References
1. Roehrborn, J Urology 2013
2. AUA Guidelines 2003, 2020
3. Roehrborn, Eur Urol Focus 2021
4. Rukstalis, Prostate Cancer Prostatic Dis 2018
4. UroLift System Instructions for Use
5. AUA BPH Guidelines, 2021
† As with any medical procedure, individual results may vary. See patient safety for more information.
*Survey of US men aged 40+ who have been diagnosed with BPH (enlarged prostate) and are/have been treated with BPH medications, conducted by Teleflex in 2020. Data on file, n=96.
**U.S. 2022 estimates based on US Market Model 2022-24 (5-17-22 FINAL), which is in part based on Symphony Health PatientSource® 2018-21, as is and with no representations / warranties, including accuracy or completeness.
§ Based on an indirect comparison of erectile and ejaculatory function and sexual satisfaction in men who received PUL in controlled studies or in men who received medical therapy in the MTOPS study.
MAC11000-02 Rev A